Bellevue Group Ag Novavax Inc Transaction History

Bellevue Group Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $725,192 - $1.49 Million	-10,400 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$134.56 - $217.97 $753,536 - $1.22 Million	-5,600 Reduced 35.0%	10,400 $1.49 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $2.84 Million - $4.33 Million	16,000 New	16,000 $3.32 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.